Erratum: Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

被引：0
|
作者：
I Breitkreutz
M S Raab
S Vallet
T Hideshima
N Raje
C Mitsiades
D Chauhan
Y Okawa
N C Munshi
P G Richardson
K C Anderson
机构：
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Leukemia (2008) 22, 1925–1932; doi:10.1038/leu.2008.174; published online 3 July 2008 Owing to a typesetting error, Figure 2b of the above article was published incorrectly. The correct figure is reproduced here. The publisher apologizes for this error and any inconvenience it may have caused.
引用
收藏
页码：1973 / 1973
相关论文
共 50 条
  • [1] Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
    Breitkreutz, I.
    Raab, M. S.
    Vallet, S.
    Hideshima, T.
    Raje, N.
    Mitsiades, C.
    Chauhan, D.
    Okawa, Y.
    Munshi, N. C.
    Richardson, P. G.
    Anderson, K. C.
    LEUKEMIA, 2008, 22 (10) : 1925 - 1932
  • [2] Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
    I Breitkreutz
    M S Raab
    S Vallet
    T Hideshima
    N Raje
    C Mitsiades
    D Chauhan
    Y Okawa
    N C Munshi
    P G Richardson
    K C Anderson
    Leukemia, 2008, 22 : 1925 - 1932
  • [3] Lenalidomide and bortezomib: Targeting osteoclastogenesis, osteoclast survival factors, and bone remodeling markers in multiple myeloma
    Breitkreutz, Iris
    Raab, Marc S.
    Vallet, Sonia
    Hideshima, Tem
    Raje, Noopur
    Mitsiades, Constantine
    Chauhan, Dharminder
    Munshi, Nikhil C.
    Richardson, Paul G.
    Anderson, Kenneth C.
    BLOOD, 2007, 110 (11) : 359A - 359A
  • [4] The role of markers of bone remodeling in multiple myeloma
    Terpos, E
    Politou, M
    Rahemtulla, A
    BLOOD REVIEWS, 2005, 19 (03) : 125 - 142
  • [5] EFFECT OF LENALIDOMIDE-BASED REGIMENS ON BONE REMODELING IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Terpos, E.
    Christoulas, D.
    Kastritis, E.
    Katodritou, E.
    Kyrtsonis, M. C.
    Papanikolaou, X.
    Maltezas, D.
    Stavropoulos, N.
    Tsionos, K.
    Repousis, P.
    Pangalis, G. A.
    Zervas, K.
    Sezer, O.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 76 - 77
  • [6] The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
    E Terpos
    M A Dimopoulos
    O Sezer
    D Roodman
    N Abildgaard
    R Vescio
    P Tosi
    R Garcia-Sanz
    F Davies
    A Chanan-Khan
    A Palumbo
    P Sonneveld
    M T Drake
    J-L Harousseau
    K C Anderson
    B G M Durie
    Leukemia, 2010, 24 : 1700 - 1712
  • [7] The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
    Terpos, E.
    Dimopoulos, M. A.
    Sezer, O.
    Roodman, D.
    Abildgaard, N.
    Vescio, R.
    Tosi, P.
    Garcia-Sanz, R.
    Davies, F.
    Chanan-Khan, A.
    Palumbo, A.
    Sonneveld, P.
    Drake, M. T.
    Harousseau, J-L
    Anderson, K. C.
    Durie, B. G. M.
    LEUKEMIA, 2010, 24 (10) : 1700 - 1712
  • [8] Bone markers in multiple myeloma
    Heider, Ulrike
    Fleissner, Claudia
    Zavrski, Ivana
    Kaiser, Martin
    Hecht, Monica
    Jakob, Christian
    Sezer, Orhan
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) : 1544 - 1553
  • [9] Continuous lenalidomide improves overall survival in multiple myeloma
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (06) : 309 - 309
  • [10] Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma
    Terpos, Evangelos
    Katodritou, Eirini
    Symeonidis, Argiris
    Zagouri, Flora
    Gerofotis, Antonis
    Christopoulou, Georgia
    Gavriatopoulou, Maria
    Christoulas, Dimitrios
    Ntanasis-Stathopoulos, Ioannis
    Kourakli, Alexandra
    Konstantinidou, Pavlina
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (02) : 559 - 568
12345